Clare Coleman, CEO of the National Family Planning and Reproductive Health Association, talks with NPR's Sarah McCammon about recent changes to Title X regulations.
New York Times health reporter Sarah Kliff tells NPR's Lulu Garcia-Navarro about Joe Biden's health care plan and how it differs from "Medicare for All."
NPR's Sarah McCammon talks to Pamela Maraldo, former CEO of Planned Parenthood. She left the organization under similar circumstances as Dr. Leana Wen, who was ousted from her position this week.
The Biden plan released this week is an update of the Affordable Care Act with controversial differences. Among them: a "public option" that covers abortion, and subsidized premiums for more people.
Provisional overdose data for 2018 show a note of hope in an overall bleak picture. But in some states, the numbers actually got worse. What explains the disparities?
Trump administration officials say drugs' list prices are like cars' sticker prices — easily negotiated. But in the life and death world of medicine, say price watchers, that analogy falls apart.
The first civil trial against an opioid manufacturer, Johnson & Johnson, has ended in Oklahoma. The verdict could affect lawsuits filed by other local and state governments coping with addiction.
Sepsis, the body's overreaction to infection, strikes more than a million Americans a year and kills more than 250,000. Evidence suggests that regulations can improve its diagnosis and patient care.
The federal government wants to deploy several new tools for catching insurers that have overcharged Medicare $30 billion in the past three years alone. But the insurance industry is balking.
Monday was the last day in a widely-watched trial about opioid addiction in Oklahoma. The state sued opioid manufacturers, but only Johnson & Johnson fought it in court after others settled.
Some physicians say connecting environmental effects of climate change — heat waves, more pollen and longer allergy seasons — to the health consequences helps them better care for patients.
Scientists are making progress in identifying environmental hazards that contribute to cancer. Researchers say many cases could be avoided if the work is accelerated.
It was a tough week for the agency in charge of implementing Trump's ambitious plans to reduce drug costs. The administration rolled back one plan and had another shot down in court.
In January, California expects to enroll 138,000 undocumented, low-income residents under age 26 in the state's version of Medicaid. But young adults say their parents need health care coverage, too.
The Justice Department has mounted a legal challenge to block the effort, claiming such a site violates federal drug laws and would enable opioid users.
Under federal law, people sexually assaulted don't have to pay for their medical forensic exams. Yet some have trouble getting the hospitals or collection agencies to stop dunning them for payment.
Expanding health benefits to more undocumented immigrants was praised by state Democrats, but some Republicans worried about California becoming a "magnet" for migrants in search of coverage.
The rule, which had support from the Trump administration and consumer rights advocates, is a blow to the White House searching for ways to pressure pharmaceutical companies to lower prices.
The ACA is again being put to the test, after a lower court judge ruled the massive health law unconstitutional. The case might yet ricochet back to the Supreme Court ahead of the 2020 election.
Two new reports from the U.S. Department of Health and Human Services have found widespread problems in hospice care and say the government needs to open its scorecards on hospice care to the public.
When medical bioethicist Travis Rieder tried to taper off pain medication after a roadway accident, he was disappointed by his doctors' reaction: "Everybody had a reason to send me to somebody else."
Traditional blood tests still do a better job flagging common inherited diseases. Gene sequencing can be useful for detecting some conditions, but the results can be difficult to interpret.
Advances in online tech are revolutionizinghealth care, with patients now emailing doctors, filling prescriptions or even getting therapy via a video session.But what if you can't afford broadband?
A pricing tool embedded in many prescribing and medical records systems lets doctors see how much each patient is likely to pay out of pocket for medicine. But the tools could be better, doctors say.
